1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002. 21:167–178.
2. Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001. 87:760–766.
3. Davila GW, Neimark M. The overactive bladder: prevalence and effects on quality of life. Clin Obstet Gynecol. 2002. 45:173–181.
4. Lee KS, Lee YS. Overactive bladder. Korean J Urol. 2007. 48:1191–1208.
5. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003. 20:327–336.
6. Knutson T, Edlund C, Fall M, Dahlstrand C. BPH with coexisting overactive bladder dysfunction--an everyday urological dilemma. Neurourol Urodyn. 2001. 20:237–247.
7. Streng T, Santti R, Talo A. Similarities and differences in female and male rat voiding. Neurourol Urodyn. 2002. 21:136–141.
8. Streng T, Santti R, Andersson KE, Talo A. The role of the rhabdosphincter in female rat voiding. BJU Int. 2004. 94:138–142.
9. Lee T, Andersson KE, Streng T, Hedlund P. Simultaneous registration of intraabdominal and intravesical pressures during cystometry in conscious rats-effects of bladder outlet obstruction and intravesical PGE2. Neurourol Urodyn. 2008. 27:88–95.
10. Conte B, Maggi CA, Giachetti A, Parlani M, Lopez G, Manzini S. Intraurethral capsaicin produces reflex activation of the striated urethral sphincter in urethane-anesthetized male rats. J Urol. 1993. 150:1271–1277.
11. Andersson KE. Bladder activation: afferent mechanisms. Urology. 2002. 59:5 Suppl 1. 43–50.
12. Andersson KE, Hedlund P. Pharmacologic perspective on the physiology of the lower urinary tract. Urology. 2002. 60:5 Suppl 1. 13–20.
13. Chung JS, Yoo HS, Lee T. Urethral dysfunction in a non-insulin dependent diabetes mellitus rat model. Korean J Urol. 2006. 47:1007–1012.
14. Hernandez RD, Hurwitz RS, Foote JE, Zimmern PE, Leach GE. Nonsurgical management of threatened upper urinary tracts and incontinence in children with myelomeningocele. J Urol. 1994. 152:1582–1585.
15. Bruschini H, Almeida FG, Srougi M. Upper and lower urinary tract evaluation of 104 patients with myelomeningocele without adequate urological management. World J Urol. 2006. 24:224–228.
16. Schroder A, Newgreen D, Andersson KE. Detrusor responses to prostaglandin E2 and bladder outlet obstruction in wild-type and Ep1 receptor knockout mice. J Urol. 2004. 172:1166–1170.
17. Jordan C. Androgen receptor (AR) immunoreactivity in rat pudendal motoneurons: implications for accessory proteins. Horm Behav. 1997. 32:1–10.
18. McKenna KE, Nadelhaft I. The organization of the pudendal nerve in the male and female rat. J Comp Neurol. 1986. 248:532–549.
19. Kontani H, Shiraoya C. Sex differences in urethral pressure response to electrical stimulation of the hypogastric nerves in rats. J Urol. 2000. 163:1364–1368.